Huseyin Pehlivanoglu

Huseyin Pehlivanoglu

Auto-generated profile, based on publicly available information

Huseyin Pehlivanoglu

Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2021 in Annals of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
SASertac Asa
Sertac Asa
KSKerim Sonmezoglu
Kerim Sonmezoglu
LULebriz Uslu-Besli
Lebriz Uslu-Besli
OSOnur Erdem Sahin
Onur Erdem Sahin
EKEmre Karayel
Emre Karayel
HSHaluk Burcak Sayman
Haluk Burcak Sayman

1 January 2020 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
LULebriz Uslu-Besli
Lebriz Uslu-Besli
KSKerim Sonmezoglu
Kerim Sonmezoglu
STSerkan Teksoz
Serkan Teksoz
EAElife Akgun
Elife Akgun
EKEmre Karayel
Emre Karayel
YBYusuf Bukey
Yusuf Bukey
Uslu-Beşli L, et al. Korean J Radiol. 2020 Jan;21:e3. https://doi.org/10.3348/kjr.2019.0268

11 February 2019 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
LULebriz Uslu-Besli
Lebriz Uslu-Besli
SSSait SAGER
Sait SAGER
EAElife Akgün
Elife Akgün
SASertaç Asa
Sertaç Asa
OŞOnur Erdem Şahin
Onur Erdem Şahin
KSKerim Sönmezoğlu
Kerim Sönmezoğlu
The aim of our study was to compare Tc-99m MDP bone scan and Ga-68 PSMA PET/CT in terms of detection of bone metastasis in prostate cancer patients. A total of 28 prostate cancer patients with bone scan and PSMA PET/CT performed within 90 days were retrospectively included in our analysis. All bone lesions were scored as negative (score-0), positive (score-1), or suspicious (score-2) for metastasis by two experienced nuclear medicine physicians. Both patient-based and region-based analyses were made for all osseous lesions. On per-patient analysis; sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were 72.7%, 52.9%, 50%, 75%, and 60.7%, respectively, for bone scan and 90.9%, 100%, 100%, 94.4%, and 96.4%, respectively, for PSMA PET/CT. On per-region analysis; sensitivity, specificity, PPV, NPV, and accuracy were 76.2%, 80.9%, 57.1%, 91.1%, and 79.8%, respectively, for bone scan and 85.7%, 100%, 100%, 95.5%, and 95.4%, respectively, for PSMA PET/CT. Ga-68 PSMA PET/CT has higher sensitivity, specificity, and accuracy compared to bone scan in terms of bone metastasis detection in prostate cancer patients. Therefore, it might be the modality of choice for patients with suspicion for metastatic disease, despite negative bone scan and conventional imaging results

24 April 2026 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
CGCansu Güneren
Cansu Güneren
LULebriz Uslu-Besli
Lebriz Uslu-Besli
OŞOnur Erdem Şahin
Onur Erdem Şahin
AMAyşe Mine Önenerk Men
Ayşe Mine Önenerk Men
HPHüseyin Pehlivanoğlu
Hüseyin Pehlivanoğlu
HSHaluk Burcak Sayman
Haluk Burcak Sayman